Johnson & Johnson (JNJ)

NYSE: JNJ · Real-Time Price · USD

267.28

+0.08 (0.03%)

At close: Sep 16, 2026, 4:00 PM EDT

267.83

+0.55 (0.21%)

After-hours: Sep 16, 2026, 7:59 PM EDT

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun '26 Jun 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 2, 2022	Jan '21 Jan 3, 2021	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Jan '17 Jan 1, 2017	Jan '16 Jan 3, 2016	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 30, 2012
Innovative Medicine Revenue	63.14B	60.40B	56.96B
MedTech Revenue	34.79B	33.79B	31.86B
Revenue (Total)	-	94.19B	88.82B

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun '26 Jun 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 2, 2022	Jan '21 Jan 3, 2021	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Jan '17 Jan 1, 2017	Jan '16 Jan 3, 2016	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 30, 2012
United States Revenue	55.77B	53.75B	50.30B
Europe Revenue	22.61B	21.54B	20.21B
Western Hemisphere ex-US Revenue	5.10B	4.88B	4.71B
Asia Pacific, Africa Revenue	14.45B	14.03B	13.59B
Revenue (Total)	-	94.19B	88.82B

EBT

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun '26 Jun 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 2, 2022	Jan '21 Jan 3, 2021	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Jan '17 Jan 1, 2017	Jan '16 Jan 3, 2016	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 30, 2012
Innovative Medicine Income Before Tax	23.07B	22.27B	18.92B
MedTech Income Before Tax	3.90B	4.11B	3.74B

Capital Expenditures

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 2, 2022	Jan '21 Jan 3, 2021	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Jan '17 Jan 1, 2017	Jan '16 Jan 3, 2016	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 30, 2012
Innovative Medicine Capital Expenditures	2.08B	1.71B
MedTech Capital Expenditures	2.50B	2.44B

Key Performance Indicators

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 2, 2022	Jan '21 Jan 3, 2021	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Jan '17 Jan 1, 2017	Jan '16 Jan 3, 2016	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 30, 2012
Sales % Change due to Transactions	8.40	5.90
Sales % Change due to Price	-3.10	-
Sales % Change due to Currency	0.70	-1.60